iShares Global Healthcare ETF company info

What does iShares Global Healthcare ETF do?
iShares Global Healthcare ETF (NYSE:IXJ) is a fund designed to track the performance of an index composed of global equities in the healthcare sector, offering investors exposure to pharmaceuticals, biotechnology, and medical device companies worldwide. This ETF is traded on the New York Stock Exchange Arca under the ticker symbol IXJ, facilitating broad access for investors seeking to diversify their portfolios with healthcare assets. The primary objective of iShares Global Healthcare ETF is to provide investment results that correspond generally to the price and yield performance of its underlying index, aiming to capture the growth and innovation happening across the global healthcare industry. Through its investments, the fund offers access to leading companies that are at the forefront of medical advancements, providing potential for both growth and income to its investors.
iShares Global Healthcare ETF company media
Company Snapshot

Is iShares Global Healthcare ETF a public or private company?

key
Ownership
Public

What sector is iShares Global Healthcare ETF in?

pie chart
Sector
ETF

Where is the head office for iShares Global Healthcare ETF?

location pin
Head Office
San Francisco, United States

What year was iShares Global Healthcare ETF founded?

founded flag
Year Founded
2001
What does iShares Global Healthcare ETF specialise in?
/Healthcare Investments /Global Exposure /Diversified Portfolio /Risk Management /ETF Trading /Financial Services

What are the products and/or services of iShares Global Healthcare ETF?

Overview of iShares Global Healthcare ETF offerings
Diversified exposure to healthcare companies worldwide, including pharmaceuticals, biotechnology, and medical devices.
Passive management aiming to track the investment results of an index composed of global healthcare equities.
Liquidity provision through exchange-traded nature, allowing for easy buying and selling.
Dividend distributions reflecting the income generated from the fund's underlying healthcare stocks.
Low expense ratio compared to actively managed funds, providing cost-effective access to healthcare sector.
Rebalancing and reconstitution to reflect changes in the healthcare industry, ensuring the fund remains aligned with its investment objective.